Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$1.06 - $36.9 $10,600 - $369,000
-10,000 Reduced 25.6%
29,063 $34,000
Q1 2022

May 06, 2022

BUY
$3.92 - $6.25 $153,126 - $244,143
39,063 New
39,063 $213,000

About PolyPid Ltd.


  • Ticker PYPD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,551,200
  • Market Cap $64.5M
  • Description
  • PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...
More about PYPD
Track This Portfolio

Track Jfg Wealth Management, LLC Portfolio

Follow Jfg Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jfg Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jfg Wealth Management, LLC with notifications on news.